MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,557
Beneficiaries
—
Total drug cost
$220K
Distinct drugs
75
Brand share
24.1%
Top prescribed drugs
Atorvastatin Calcium177 claims
Levothyroxine Sodium167 claims
Apixaban146 claims
Torsemide113 claims
Rivaroxaban106 claims
QUALITY · MIPS · 2024
Final MIPS score
89.8
Quality
68.4
Cost
81.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.62%
Group
CROSS-REFERENCE